Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.27 USD | +0.11% | -2.53% | -19.29% |
04:20pm | Maxim Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
02:35pm | Redburn Atlantic Adjusts Price Target on Gilead Sciences to $117 From $120 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.29% | 81.3B | |
+32.02% | 704B | |
+28.38% | 577B | |
-4.63% | 348B | |
+17.90% | 327B | |
+4.48% | 288B | |
+14.74% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.63% | 147B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead's Trodelvy 'Significantly Improves' Overall Survival in Pre-Treated Metastatic Breast Cancer Patients